SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 0.33 |
| Enterprise Value ($M) | -6.35 |
| Book Value ($M) | 24.54 |
| Book Value / Share | 5.04 |
| Price / Book | 0.01 |
| NCAV ($M) | -15.61 |
| NCAV / Share | -3.21 |
| Price / NCAV | -0.02 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.73 |
| Return on Assets (ROA) | -0.57 |
| Return on Equity (ROE) | -1.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.60 |
| Current Ratio | 0.62 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.38 |
| Assets | 46.53 |
| Liabilities | 21.99 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | 3i, LP | 9.90 | 46.00 | |
| 13G | Jaigobind Ramnarain Joseph | 9.13 | ||
| 13D/A | Wolf Jeffrey Alan | 9.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
Financial data and stock pages provided by
Fintel.io